Investment10 Dec 2025, 03:02 pm
Fermenta Biotech to Invest INR 110 Crore at Dahej Facility for Plant-based Vitamin D3, Green Chemistry Enzymes, and Vitamin D3 Derivatives
AI Summary
Fermenta Biotech Limited, a leading manufacturer of premium-grade nutritional ingredients, intermediates, nutritional premixes and green chemistry, has approved a capital investment of INR 110 crore for expanding capacities at its existing Dahej, Gujarat facility. The investment will be implemented in phases across FY26 and FY27, and will expand capacity across Plant-Based Vitamin D3, Green Chemistry Enzymes, and Vitamin D3 Derivatives.
Key Highlights
- INR 110 crore investment in new and expanded capacities for high-growth business verticals
- Commercial-scale production of plant-based Vitamin D3 following India patent grant
- Enzyme capacity expansion for green chemistry fermentation including CAL-B Lipase and Penicillin G Acylase
- Commercial-scale production of Vitamin D3 derivatives
- Reinforces Fermenta's leadership in Vitamin D3 and sustainable biocatalysis
- Expansion of fermentation capacity for Green Chemistry Enzymes by approximately 75KL
- Establishment of commercial-scale manufacturing for Vitamin D3 derivatives, including Calcifediol